Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ELK | Shares now valueless | 18/10/21 | 0 | 1.1K | |||
|
|||||||
ELK | Ann: Removal from Official List | 16/03/20 | 0 | 1.8K | |||
|
|||||||
ELK | Ann: Update by Administrator | 22/02/20 | 8 | 26K | |||
|
|||||||
ELK | Ann: Bimonthly Report to Creditors | 28/01/20 | 0 | 1.9K | |||
|
|||||||
ELK | Ann: Update by Administrator | 10/10/19 | 0 | 2.0K | |||
|
|||||||
ELK | From McGrathNicol | 04/10/19 | 9 | 9.5K | |||
|
|||||||
ELK | No news is good news | 11/09/19 | 2 | 2.1K | |||
|
|||||||
ELK | I think there waiting for us to give up hope | 26/08/19 | 0 | 817 | |||
|
See All Discussions